相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。OPTN/SRTR 2019 Annual Data Report: Kidney
A. Hart et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Induction therapy with mesenchymal stromal cells in kidney transplantation: a meta-analysis
Lingfei Zhao et al.
STEM CELL RESEARCH & THERAPY (2021)
Donor apoptotic cell-based therapy for effective inhibition of donor-specific memory T and B cells to promote long-term allograft survival in allosensitized recipients
Anil Dangi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study
Geertje J. Dreyer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies
Guido Moll et al.
FRONTIERS IN IMMUNOLOGY (2020)
MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
Guido Moll et al.
FRONTIERS IN IMMUNOLOGY (2020)
Postnatal Involution and Counter-Involution of the Thymus
Jennifer E. Cowan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up
Robin Schmitz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial
Andy Roemhild et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Receptor tyrosine kinase MerTK suppresses an allogenic type I IFN response to promote transplant tolerance
Lei Zhang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines
Guido Moll et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
Henry Caplan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
Andreas Robert Rudolf Weiss et al.
FRONTIERS IN IMMUNOLOGY (2019)
Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes
Amar Singh et al.
NATURE COMMUNICATIONS (2019)
Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study
Pauline Erpicum et al.
KIDNEY INTERNATIONAL (2019)
The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation
Christian Andreas Radu et al.
LANGENBECKS ARCHIVES OF SURGERY (2018)
Updated follow-up of a tolerance protocol in HLA-identical renal transplant pairs given donor hematopoietic stem cells
Joseph R. Leventhal et al.
HUMAN IMMUNOLOGY (2018)
Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial
Qipeng Sun et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction
Cesar Ariel Keller et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015
Maarten Coemans et al.
KIDNEY INTERNATIONAL (2018)
Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation
Paul Lohan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Danger signals in regulating the immune response to solid organ transplantation
Jamie L. Todd et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study
Olivier Detry et al.
JOURNAL OF HEPATOLOGY (2017)
Belatacept and Long-Term Outcomes in Kidney Transplantation
Flavio Vincenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing
Raghavan Chinnadurai et al.
STEM CELLS (2016)
Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study
Guang-hui Pan et al.
ONCOTARGET (2016)
Umbilical Cord-derived Mesenchymal Stem Cells Instruct Monocytes Towards an IL10-producing Phenotype by Secreting IL6 and HGF
Yinan Deng et al.
SCIENTIFIC REPORTS (2016)
Chimerism, Graft Survival, and Withdrawal of Immunosuppressive Drugs in HLA Matched and Mismatched Patients After Living Donor Kidney and Hematopoietic Cell Transplantation
J. D. Scandling et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Phagocytosis of apoptotic cells in homeostasis
Sanja Arandjelovic et al.
NATURE IMMUNOLOGY (2015)
First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation
Yorick Soeder et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: A pilot study
Chetan Mudrabettu et al.
NEPHROLOGY (2015)
Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors
A. D. Kirk et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Preemptive Donor Apoptotic Cell Infusions Induce IFN-γ-Producing Myeloid-Derived Suppressor Cells for Cardiac Allograft Protection
Jane Bryant et al.
JOURNAL OF IMMUNOLOGY (2014)
Multipotent Stromal Cells Induce Human Regulatory T Cells Through a Novel Pathway Involving Skewing of Monocytes Toward Anti-inflammatory Macrophages
Sara M. Melief et al.
STEM CELLS (2013)
Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Donor Stem Cell Infusion: Durable Chimerism Predicts Outcome
Joseph Leventhal et al.
TRANSPLANTATION (2013)
Donor-Derived Mesenchymal Stem Cells Combined With Low-Dose Tacrolimus Prevent Acute Rejection After Renal Transplantation: A Clinical Pilot Study
Yanwen Peng et al.
TRANSPLANTATION (2013)
Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study
Marlies E. J. Reinders et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants
J. D. Scandling et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Localization of Mesenchymal Stromal Cells Dictates Their Immune or Proinflammatory Effects in Kidney Transplantation
F. Casiraghi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Intragraft CD11b+IDO+ Cells Mediate Cardiac Allograft Tolerance by ECDI-Fixed Donor Splenocyte Infusions
G. Chen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants A Randomized Controlled Trial
Jianming Tan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation
Joseph Leventhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
Guido Moll et al.
STEM CELLS (2012)
Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal
K. E. Lamb et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
The Risk and Opportunity of Homeostatic Repopulation
P. Stock et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Long-Term Follow-Up of Recipients of Combined Human Leukocyte Antigen-Matched Bone Marrow and Kidney Transplantation for Multiple Myeloma With End-Stage Renal Disease
Thomas R. Spitzer et al.
TRANSPLANTATION (2011)
A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
F. Vincenti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study
Rakhi Pal et al.
CYTOTHERAPY (2009)
Bone Marrow-Derived Mesenchymal Stem Cells Inhibit Acute Rejection of Rat Liver Allografts in Association With Regulatory T-Cell Expansion
Y. Wang et al.
TRANSPLANTATION PROCEEDINGS (2009)
Kidney transplantation: Mechanisms of rejection and acceptance
Lynn D. Cornell et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells
Federica Casiraghi et al.
JOURNAL OF IMMUNOLOGY (2008)
Brief report: HLA-mismatched renal transplantation without maintenance immunosuppression
Tatsuo Kawai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Brief report: Tolerance and chimerism after renal and hematopoietic-cell transplantation
John D. Scandling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms
Xunrong Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
Stephanie J. Lee et al.
BLOOD (2007)
CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation
Jonathan P. Pearl et al.
TRANSPLANTATION (2007)
Inhibition of heart allograft rejection with mitomycin C-treated donor dendritic cells
Lucian P. Jiga et al.
TRANSPLANTATION (2007)
Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle
Rajesh Ramasamy et al.
TRANSPLANTATION (2007)
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation:: In vivo and in vitro analyses
Y. Fudaba et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
AC Webster et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Costimulation blockade with belatacept in renal transplantation
F Vincenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells
XX Jiang et al.
BLOOD (2005)
IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates
EH Preston et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients
HM Lazarus et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion
JP Pearl et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation
SA Quezada et al.
BLOOD (2003)
Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation
H Xu et al.
JOURNAL OF IMMUNOLOGY (2003)
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
A Bartholomew et al.
EXPERIMENTAL HEMATOLOGY (2002)
Anti-TCR-specific DNA vaccination demonstrates a role for a CD8+ T cell clone in the induction of allograft tolerance by donor-specific blood transfusion
C Vignes et al.
JOURNAL OF IMMUNOLOGY (2000)
Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8(+) T cells and prolonged craft survival in a CTLA4-dependent manner
NN Iwakoshi et al.
JOURNAL OF IMMUNOLOGY (2000)